A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination with Itraconazole in Healthy Participants

Trial Identifier:	D6970C00005
Sponsor:	AstraZeneca
NCTID::	NCT06357520
Start Date:	April 2024
Primary Completion Date:	June 2024
Study Completion Date:	June 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.